🇮🇳 India Clinical Trials Database
Search 3,400+ clinical trials conducted in India. Access comprehensive trial data including phases, sponsors, outcomes, and locations from CTRI & International Registries. Part of Pure Global AI's free database with 840,000+ trials worldwide.
What is the India clinical trials database?
The India clinical trials database contains over 3,400 clinical trials registered through CTRI (Clinical Trials Registry - India). It includes trials for drugs, medical devices, biologics, and behavioral interventions conducted in India.
How do I search for clinical trials in India?
Enter a disease name, drug name, sponsor, or trial ID in the search box above. You can filter results by phase, status, and intervention type.
What information is available for each trial?
Each trial listing includes: trial ID, study title, phase, status, sponsor, enrollment, start/end dates, disease/condition, intervention, primary outcomes, and location information.
Is this database free to use?
Yes, this database is completely free. Pure Global AI provides free access to clinical trial data to help researchers, patients, and companies find relevant clinical research in India.
How often is the database updated?
The database aggregates data from CTRI (Clinical Trials Registry - India) and is updated regularly. The full database contains 840,000+ trials from 20+ registries worldwide.
What regulatory body oversees clinical trials in India?
CDSCO (Central Drugs Standard Control Organisation) oversees clinical trials in India. Ethics approval is required from Institutional Ethics Committees.
What types of trials are common in India?
India has significant trials in infectious diseases (TB, malaria), diabetes, and oncology. The large, treatment-naive population makes India attractive for global trials.
About This Database
This database provides free access to clinical trial data from India. Data is aggregated from CTRI and international registries. Use this tool to research ongoing trials, find recruitment opportunities, analyze competitive landscape, and track drug/device development. India offers access to a large, diverse patient population and cost-effective clinical research.